How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Temperature Controlled Pharmaceutical Containers Market
- By Container Type: Refrigerated Containers, Insulated Containers, Active Temperature Controlled Containers, Passive Temperature Controlled Containers, Cryogenic Containers
- By Temperature Range: 2°C to 8°C, -20°C to -10°C, -80°C and below, 15°C to 25°C
- By Material: Plastic Containers, Aluminum Containers, Stainless Steel Containers, Composite Material Containers
- By End User: Pharmaceutical Manufacturers, Biotechnology Companies, Clinical Research Organizations, Hospitals and Healthcare Facilities, Cold Chain Logistics Providers
- By Application: Vaccine Transportation, Biologics Shipping, Clinical Trial Material Transport, Cold Chain Storage, Diagnostic Sample Transport
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Refrigerated Containers leads By Container Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Temperature Controlled Pharmaceutical Containers Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Container Type 5
Temperature Range 4
Material 4
End User 5
Application 5
Companies profiled
Thermo Fisher Scientific
Pelican BioThermal
Sonoco ThermoSafe
Va-Q-Tec AG
Cryopak
Softbox Systems
CSafe Global
Intelsius (part of Sonoco ThermoSafe)
B Medical Systems
World Courier (a part of AmerisourceBergen)
Envirotainer
Marken (a UPS company)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Pelican BioThermal
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sonoco ThermoSafe
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Va-Q-Tec AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Cryopak
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Softbox Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →CSafe Global
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Intelsius (part of Sonoco ThermoSafe)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →B Medical Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →World Courier (a part of AmerisourceBergen)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Envirotainer
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Marken (a UPS company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cold Chain Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →MediCool
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Polar Tech Industries
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,816M by 2033 · 11.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Refrigerated Containers59.7
- Insulated Containers14.2
- Active Temperature Controlled Containers7.6
- Passive Temperature Controlled Containers7.2
- Cryogenic Containers11.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,210M → $3,101M · 12.5%
Europe$843.2M → $2,268M · 13.2%
Asia Pacific$769.9M → $1,790M · 11.1%
Latin America$476.6M → $1,256M · 12.9%
Middle East and Africa$366.6M → $846.6M · 11.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.532026
11.552027
11.572028
11.572029
11.602030
11.602031
11.612032
11.622033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific12.6
- Pelican BioThermal20.1
- Sonoco ThermoSafe17.0
- Va-Q-Tec AG8.8
- Cryopak7.0
- Softbox Systems6.4
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Container Type14.8%
Temperature Range17.7%
Material22.1%
End User16.0%
Application29.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe24.5
- Asia Pacific19.3
- Latin America13.6
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 74 | 77 | 77 | 78 | 90 | 91 | 81 |
| Pelican BioThermal | 72 | 75 | 86 | 93 | 84 | 83 | 82 |
| Sonoco ThermoSafe | 62 | 65 | 68 | 70 | 85 | 67 | 70 |
| Va-Q-Tec AG | 70 | 74 | 76 | 79 | 58 | 72 | 72 |
| Cryopak | 52 | 69 | 72 | 74 | 72 | 74 | 69 |
| Softbox Systems | 66 | 69 | 57 | 61 | 60 | 63 | 63 |
| CSafe Global | 53 | 56 | 50 | 50 | 50 | 52 | 52 |
| Intelsius (part of Sonoco ThermoSafe) | 45 | 45 | 53 | 35 | 38 | 59 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Pelican BioThermal
- Sonoco ThermoSafe
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Pelican BioThermal | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Sonoco ThermoSafe | ◐ | ◐ | − | − | ◐ | ◐ |
| Va-Q-Tec AG | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Cryopak | − | ◐ | ◐ | ✓ | − | ◐ |
| Softbox Systems | ◐ | − | − | ◐ | − | ◐ |
| CSafe Global | − | − | − | − | ◐ | − |
| Intelsius (part of Sonoco ThermoSafe) | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Pelican BioThermal82
2Thermo Fisher Scientific81
3Va-Q-Tec AG72
4Sonoco ThermoSafe70
5Cryopak69
6Softbox Systems63
7CSafe Global52
8Intelsius (part of Sonoco ThermoSafe)46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificPelican BioThermal
Challenger3
Strong scale, closing on the leaders.
Sonoco ThermoSafeVa-Q-Tec AGCryopak
Contender1
Focused players with pockets of strength.
Softbox Systems
Niche2
Specialists in a single segment or region.
CSafe GlobalIntelsius (part of Sonoco ThermoSafe)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Container Type in North America, then scale across Temperature Controlled Pharmaceutical Containers Market — a $380M beachhead inside a $5.89B market.
Beachhead (SOM)$380Mobtainable near-term
Serviceable (SAM)$2.05Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Refrigerated Containers
Best fit — highest urgency & budget in Container Type.
Economic buyer79 fit
Insulated Containers
Strong fit — clear ROI and a fast path to value.
End user67 fit
Active Temperature Controlled Containers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Container Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Temperature Range & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Material
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel25%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Container Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Temperature Controlled Pharmaceutical Containers Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified23%
Evaluation13%
Closed-won6%
$11.4KCAC
$42KLTV
3.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Temperature Controlled Pharmaceutical Containers Market is a resilient opportunity — $1.44B by 2033, compounding at 3.5%.
TAM · 2025$1.09Btoday
TAM · 2033$1.44Bforecast
CAGR3.5%2027–2033
Cumulative$11.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.44BTotal addressable market
SAM$585MServiceable available market
SOM$120MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.5% CAGR
Demand compounds through 2033, outpacing GDP across Container Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Container Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.44BLarge & growingTAM by 2033 at 3.5% CAGR
$585MServiceable nowreachable with today’s model
$120MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.12BBear2.3% CAGR
$1.44BBase3.5% CAGR
$1.85BBull4.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Temperature Range optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Temperature Controlled Pharmaceutical Containers Market — a $4.59B market by 2033. Plan: grow share from 9.4% to 14.9%.
Market size · 2033$4.59Btotal addressable
Market CAGR4.4%2027–2033
Target share14.9%from 9.4% today
Revenue ambition$684Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.4% | 14.9% | On track |
| Revenue | $425M | $684M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 33.9% | 42.0% | On track |
| Customer retention | 90.9% | 94.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Container Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Temperature Range capability
A defensible second engine — invest in Temperature Range to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Container Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Temperature Range
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $81M capacity & capability investment
- Greenlight bolt-on M&A in Temperature Range
- Authorise North America expansion plan
- Fund R&D program for Container Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Temperature Controlled Pharmaceutical Containers Market conversation — a $3.16B market you can size, segment and defend in minutes.
Market size · 2033$3.16Btotal opportunity
Growth7.1%CAGR to 2033
Addressable buyers1,765+accounts in scope
Typical ROI4.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Container Type
Goal Grow share in Container Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.4×return on cost, year one
< 3 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificPelican BioThermalSonoco ThermoSafeVa-Q-Tec AGCryopakSoftbox SystemsCSafe GlobalIntelsius (part of Sonoco ThermoSafe)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Temperature Controlled Pharmaceutical Containers Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Temperature Controlled Pharmaceutical Containers Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Temperature Controlled Medicine Container Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportTemperature Controlled Logistics (TCL) in Biopharmaceutical Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportTemperature Controlled Box For Medicine Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportTemperature Ablation Catheter Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportTemoporfin(mTHPC) Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportTemocapril Hydrochloride API Market
Market size, share, segmentation and regional forecast.
$398M market · 2025 base year
View reportTelomere Detection Market
Market size, share, segmentation and regional forecast.
$656M market · 2025 base year
View reportTelocollagen Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportTelmisartan Dispersible Tablets Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportTelmisartan API Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportTeleultrasound System Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportTele-ultrasound Solution Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.